Hepatitis C immune globulin (human)

DB17813Investigational

Hepatitis C immune globulin (human): Overview.

Mechanism: Pharmacologically active on Genome polyprotein
Curator reviewed
Also known as: Civacir · HCIG · HCIGIV · HCVIG · Hepatitis C human polyclonal immune globulin

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Hepatitis C immune globulin (human), and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.